110 related articles for article (PubMed ID: 9450474)
1. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility.
Esteller M; Garcia A; Martinez-Palones JM; Xercavins J; Reventos J
Carcinogenesis; 1997 Dec; 18(12):2307-11. PubMed ID: 9450474
[TBL] [Abstract][Full Text] [Related]
2. Endometrial carcinoma in tamoxifen-treated breast cancer patient: clinicopathological, immunohistochemical, and genetic analysis.
Esteller M; Garcia A; Martinez-Palones JM; Xercavins J; Reventos J
Int J Gynecol Pathol; 1999 Oct; 18(4):387-91. PubMed ID: 10542949
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and genetic alterations in endometrioid carcinoma of the uterus with villoglandular differentiation.
Esteller M; Garcia A; Martinez-Palones JM; Xercavins J; Reventos J
Am J Clin Pathol; 1999 Mar; 111(3):336-42. PubMed ID: 10078108
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population.
Song C; Xing D; Tan W; Wei Q; Lin D
Cancer Res; 2001 Apr; 61(8):3272-5. PubMed ID: 11309278
[TBL] [Abstract][Full Text] [Related]
5. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer.
Campbell IG; Baxter SW; Eccles DM; Choong DY
Breast Cancer Res; 2002; 4(6):R14. PubMed ID: 12473175
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States).
McGrath M; Hankinson SE; De Vivo I
Cancer Causes Control; 2007 Dec; 18(10):1123-30. PubMed ID: 17717632
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia.
Piyathilake CJ; Macaluso M; Johanning GL; Whiteside M; Heimburger DC; Giuliano A
Anticancer Res; 2000; 20(3A):1751-7. PubMed ID: 10928104
[TBL] [Abstract][Full Text] [Related]
9. Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women.
Xu WH; Shrubsole MJ; Xiang YB; Cai Q; Zhao GM; Ruan ZX; Cheng JR; Zheng W; Shu XO
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):281-7. PubMed ID: 17301261
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci.
Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
Br J Cancer; 1997; 75(9):1385-8. PubMed ID: 9155064
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.
Ma J; Stampfer MJ; Giovannucci E; Artigas C; Hunter DJ; Fuchs C; Willett WC; Selhub J; Hennekens CH; Rozen R
Cancer Res; 1997 Mar; 57(6):1098-102. PubMed ID: 9067278
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma.
Esinler I; Aktas D; Alikasifoglu M; Tuncbilek E; Ayhan A
Int J Gynecol Cancer; 2006; 16(3):1407-11. PubMed ID: 16803538
[TBL] [Abstract][Full Text] [Related]
13. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
[TBL] [Abstract][Full Text] [Related]
14. [C677T genetic polymorphism of methylenetetrahydrofolate reductase in premature coronary heart disease].
Xu H; Chen Z; Tang J; Zhu D; Zhang C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Apr; 21(2):118-21. PubMed ID: 12569666
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.
Sohda S; Arinami T; Hamada H; Yamada N; Hamaguchi H; Kubo T
J Med Genet; 1997 Jun; 34(6):525-6. PubMed ID: 9192280
[TBL] [Abstract][Full Text] [Related]
16. Response to "genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A".
Isotalo PA; Donnelly JG
Am J Med Genet; 2002 Jun; 110(2):191-2. PubMed ID: 12116261
[No Abstract] [Full Text] [Related]
17. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
[TBL] [Abstract][Full Text] [Related]
18. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR.
Goyette P; Christensen B; Rosenblatt DS; Rozen R
Am J Hum Genet; 1996 Dec; 59(6):1268-75. PubMed ID: 8940272
[TBL] [Abstract][Full Text] [Related]
19. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
Balta G; Yuksek N; Ozyurek E; Ertem U; Hicsonmez G; Altay C; Gurgey A
Am J Hematol; 2003 Jul; 73(3):154-60. PubMed ID: 12827651
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 polymorphism and risk of gynecological malignancy in Japan.
Sugawara T; Nomura E; Sagawa T; Sakuragi N; Fujimoto S
Int J Gynecol Cancer; 2003; 13(6):785-90. PubMed ID: 14675315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
